Pharmacy news

• Lyons Pharmacy starts 'Restaurant: Impossible' renovations - Cecil Whig

  18-02-2015 02:33 via cecildaily.com
  
  Cecil Whig
  Lyons Pharmacy starts 'Restaurant: Impossible' renovations
  Cecil Whig
  Minihane's Pub and Restaurant displayed this sign outside their restaurant as filming began on the Food Network's “Restaurant: Impossible” episode at Lyons Pharmacy Tuesday afternoon. Restaurant Impossible Filming. CECIL WHIG PHOTO BY SAM ...
  
  Read more

• New Teva Resource Aims to Move LAIs Earlier in Schizophrenia Care

  25-09-2026 16:12 via pharmacypracticenews.com
  
  Originally published by our sister publication Specialty Pharmacy Continuumfigure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }liaksandr Marko, alexkoral - stock.adobe.comBy Gina ShawTeva has launched
  
  Read more

• Specialty Pharmacy Teams Can Play Helpful Roles in Lupus Management

  25-09-2026 15:10 via pharmacypracticenews.com
  
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Karen BlumSystemic lupus erythematosus (SLE), or lupus, is difficult to diagnose. Fortunately, specialty pharmacy teams can find updated treatment information through a guideline released in 2025 and help patients in multiple ways, an SLE expert noted during the National Association of Specialty Pharmacy’s inSPire2026 meeting, in National Harbor, Maryland.“The course of the disease is marked by flares and p
  
  Read more

• RFID Can Help Hospitals Control High-cost Medication Inventories

  25-09-2026 04:02 via pharmacypracticenews.com
  
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Robert HowardHospitals are under growing pressure to manage increasingly complex and costly medication inventories. Specialty drugs, biologics, and other high-value therapies represent a significant and expanding share of pharmacy budgets, yet many health systems still lack real-time visibility into where these medications are stored, how they are being used, and whether they are being protected from loss or waste. As
  
  Read more

• Advertisement

• Pharmacies a Hot Target for Phishing, Vishing, and Other Cyberattacks

  24-09-2026 18:54 via pharmacypracticenews.com
  
  Originally published by our sister publication Specialty Pharmacy Continuumfigure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }Studio KN – stock.adobe.comBy Karen BlumImagine this scenario: You c
  
  Read more

• Quality Specialty Pharmacy Programs Need Data, Dedicated Staffs

  24-09-2026 17:00 via pharmacypracticenews.com
  
  Originally published by our sister publication Specialty Pharmacy Continuumfigure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }StratfordProductions - stock.adobe.comBy Karen BlumDesigning a quality spe
  
  Read more

• When Law Enforcement Comes Knocking, Be Prepared

  24-09-2026 12:35 via pharmacypracticenews.com
  
  Originally published by our sister publication Specialty Pharmacy Continuumfigure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }Studio KN – stock.adobe.comBy Karen BlumIf representatives from the
  
  Read more

• Cold Chain Shipping: Why Pharmacies Struggle and How to Strengthen Compliance

  23-09-2026 19:00 via pharmacypracticenews.com
  
  figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }Credit: Grispb – stock.adobe.com.By Karen Spano, RPh, HDDPAcross pharmacy settings—from independent and hospital pharmacies to large nati
  
  Read more

• Advertisement

• New URAC Accreditation Offers Path to AI Implementation With Oversight

  23-09-2026 15:40 via pharmacypracticenews.com
  
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Marcus A. BanksThis summer, URAC introduced its Health Care AI Accreditation to establish standards for responsible deployment of artificial intelligence. A speaker from one of the first recipients of the new accreditation discussed how AI can, with guardrails, improve pharmacy operations and patient experience at the National Association of Specialty Pharmacy’s inSPire2026 meeting, in National Harbor, Maryland.f
  
  Read more

• What to Know About Bixlenvo for HIV

  23-09-2026 12:11 via pharmacypracticenews.com
  
  By Meaghan Lee Callaghan What do you know about the newly approved HIV combination drug bictegravir/lenacapavir (Bixlenvo, Gilead)?Following the new FDA approval, Onyema Ogbuagu, MBBCh, MD, a professor at Yale University, in New Haven, sat down with Infectious Disease Special Edition to talk about the drug. Dr. Ogbuagu, who is also the director of the Yale Antivirals and Vaccines Research Program (formerly HIV Clinical Trials program), should know best—he was a study investigator
  
  Read more

• Monitor Nutrition and Muscle Loss in Patients on Incretin-Based Obesity Drugs

  22-09-2026 18:31 via pharmacypracticenews.com
  
  By Gina ShawAs much as 40% of the weight patients lose on incretin-based obesity medications can come from lean mass, and roughly 1 in 5 meets the criteria for malnutrition after a year of therapy, cautioned presenters during a Malnutrition Awareness Week 2026 webinar, held by the American Society for Parenteral and Enteral Nutrition.“Incretin-based medications are not the problem. The problem is the lack of nutrition education, guidance, and monitoring,” said Colleen Dawkins, FNP-C,
  
  Read more

• Jideytro Approved for Previously Treated ROS1-Positive NSCLC

  22-09-2026 04:00 via pharmacypracticenews.com
  
  Originally published by our sister publication Clinical Oncology NewsBy Sarah TilyouThe FDA approved zidesamtinib (Jideytro, GlaxoSmithKline) for adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC) who have received at least one prior ROS1 tyrosine kinase inhibitor (TKI).figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block
  
  Read more

• Are We Aiming at the Right End Points in Crohn’s Disease?

  21-09-2026 17:10 via pharmacypracticenews.com
  
  Originally published by our sister publication Gastroenterology & Endoscopy NewsBy Gina ShawLAS VEGAS—Treat-to-target strategies have become foundational to Crohn’s disease management, but at the 2026 Crohn’s & Colitis Congress, experts focused on a central question: Are the end points being chased in trials and guidelines the ones that actually predict meaningful outcomes in real-world patients?The STRIDE II recommendations from the International Organization for the S
  
  Read more

• AI Tools Require Strong Governance and Rigorous Vetting

  21-09-2026 03:00 via pharmacypracticenews.com
  
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Marcus A. BanksArtificial intelligence tools for clinical decision-making hold promise but may not be ready for everyday use, according to a discussion forum at the 2026 Critical Care Congress, in Chicago. Financial limitations may impede AI adoption as well.figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto;
  
  Read more

• Oral Paclitaxel Provides Infusion-Free Alternative in MBC

  20-09-2026 17:01 via pharmacypracticenews.com
  
  Originally published by our sister publication Clinical Oncology NewsBy Jennifer KulpaWeekly paclitaxel is a common first-line option in HER2-negative metastatic breast cancer (mBC), but it requires frequent infusions, and its use can be limited by cumulative neuropathy and infusion-related reactions. In the OPTIMAL phase 3 trial, an oral paclitaxel formulation, DHP107, achieved disease control similar to weekly IV paclitaxel with lower rates of peripheral neuropathy and hypersensitivity reactio
  
  Read more

• FDA Issues Serious Warning to Patients Taking Tavneos

  19-09-2026 16:56 via pharmacypracticenews.com
  
  Originally published by our sister publication Gastroenterology & Endoscopy NewsBy GEN StaffThe FDA recently issued a warning related to avacopan (Tavneos, Amgen) after the drug was found to be associated with serious cases of drug-induced liver injuries, some fatal and some involving vanishing bile duct syndrome, which can lead to permanent liver damage.“Although hepatoxicity is a serious adverse reaction for Tavneos identified in premarket clinical trials and described in product lab
  
  Read more

• Advanced Therapies Push Into Community Oncology, But Infrastructure Gaps Remain

  18-09-2026 16:53 via pharmacypracticenews.com
  
  Originally published by our sister publication Clinical Oncology NewsBy Jennifer KulpaResponses to a national web-based survey of oncology and hematology physicians and administrators described rapid expansion of cell, gene, and other advanced therapies and shifts in delivery from inpatient academic centers toward outpatient and community sites of care.A report from Cardinal Health summarizing the survey findings identifies key clinical, operational, and economic barriers to broader adoption in
  
  Read more

• Dovato Noninferior to Biktarvy at 48 Weeks

  17-09-2026 16:44 via pharmacypracticenews.com
  
  Originally published by our sister publication Infectious Disease Special EditionBy Ethan CoveyA two-drug regimen of dolutegravir-lamivudine (DTG/3TC; Dovato, ViiV Healthcare) was noninferior to bictegravir, emtricitabine, and tenofovir alafenamide (BIC/FTC/TAF; Biktarvy, Gilead) for virologic suppression at 48 weeks among adults initiating antiretroviral therapy, according to results from the phase 3b VOGUE trial presented at AIDS 2026, in Rio de Janeiro (oral presentation OAB0106LB and in-pers
  
  Read more

• GLP-1 Market Drives Specialty Pipeline Expansion

  17-09-2026 15:28 via pharmacypracticenews.com
  
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Karen BlumGlucagon-like peptide-1 (GLP-1) medications for the management of obesity and type 2 diabetes will continue to dominate the specialty pipeline in 2026, including oral options, novel targets, and dual agents.GLP-1 product sales hit approximately $132 billion in 2025, said Dan Powell, PharmD, the patient solutions manager and pharmacist-in-charge of the Walgreens Gene and Cell Services Pharmacy, in Pittsburgh,
  
  Read more

• Will PAPs Be on Life Support in the Next 18 Months?

  16-09-2026 15:26 via pharmacypracticenews.com
  
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Gina ShawPatient assistance programs (PAPs) are facing a flood of policy rollbacks and other financial pressures that pose a major threat to PAP efficacy over the next 18 months, experts noted during the 2026 Patient Assistance and Access Programs (PAP) Conference, in Philadelphia.Patients already are showing their concern. About 1 in 4 say an out-of-pocket cost of just $50 to $100 may be enough to stop them from start
  
  Read more

• Managing the Risks of Million-Dollar Therapies

  15-09-2026 15:22 via pharmacypracticenews.com
  
  Originally published by our sister publication Specialty Pharmacy ContinuumBy Fran KritzManagement of ultra–high-cost (UHC) pharmaceuticals such as gene and cell therapies requires active involvement from all key stakeholders to ensure best patient outcomes and financial returns, according to a session at the ASHP Midyear 2025 Clinical Meeting & Exhibition, in Las Vegas.The presenters emphasized the important role pharmacists play in every step of the process, from cell collection to a
  
  Read more

• AHA Statement Makes the Case for Screening and Treating Iron Deficiency Before Cardiac Surgery

  15-09-2026 13:17 via pharmacypracticenews.com
  
  figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }McMahon Publishing.By Gina ShawAs many as 1 in 2 adults scheduled for cardiac surgery are anemic when they arrive, yet the most common cause—ir
  
  Read more

• Pooled Data Strengthen Case for IV Iron in Heart Failure

  15-09-2026 13:04 via pharmacypracticenews.com
  
  figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }.Vector Juice - stock.adobe.comBy Karen BlumNew pooled patient-level data strengthen the evidence that IV iron can improve outcomes in patients with
  
  Read more

• Iron Deficiency in Early Pregnancy Linked to Lower Toddler Language and Motor Scores

  15-09-2026 10:42 via pharmacypracticenews.com
  
  figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }Kakenimages.com - stock.adobe.com.By Gina ShawIron deficiency in early pregnancy, even without anemia, was associated with reduced neonatal iron stor
  
  Read more

• Experts Call for Stronger Healthcare AI Oversight

  14-09-2026 18:45 via pharmacypracticenews.com
  
  Originally published by our sister publication Specialty Pharmacy Continuumfigure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }hyframeshot, ICONIC_WORLD - stock.adobe.com.By Marcus A. BanksArtificial i
  
  Read more

• With Planning, Successful Pregnancy Possible for Patients With IBD

  14-09-2026 14:55 via pharmacypracticenews.com
  
  Originally published by our sister publication Gastroenterology & Endoscopy NewsBy Marcus A. BanksNEW YORK CITY—Many women with inflammatory bowel disease are likely hesitant to have children, but with proactive discussion and thoughtful management, IBD need not stop a woman from pursuing this dream, said Laura Sahyoun, MD, a gastroenterologist and an assistant professor of medicine at Weill Cornell Medicine who spoke about this topic at an IBD symposium hosted by Weill Cornell earlier
  
  Read more

• People Living With HIV Have Comparable Long-Term Outcomes After Modern Liver Transplantation

  13-09-2026 16:38 via pharmacypracticenews.com
  
  Originally published by our sister publication Infectious Disease Special EditionBy Jordan DavidsonIn the modern era of liver transplantation, people living with HIV can have similar outcomes to people without HIV, according to new research presented at the American Transplant Congress 2026, in Boston.figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcap
  
  Read more

• Insider Access to Patient Records Rose 17% in 2025, Even as Breaches Grew Smaller

  13-09-2026 02:00 via pharmacypracticenews.com
  
  By Gina ShawUnauthorized access to patient records at U.S. healthcare organizations rose 17% year over year in 2025, even as the number of individuals affected fell sharply, according to Bluesight’s 2026 Privacy Trends Report. The number of unauthorized-access incidents grew more frequent, even as each one reached fewer people, with the number affected falling from roughly 16 million in 2024 to just under 2 million in 2025, per HIPAA Journal data cited in the report.While hackers and other
  
  Read more

• What You Should Know About Pediatric HIV Treatment

  12-09-2026 16:31 via pharmacypracticenews.com
  
  By Meaghan Lee CallaghanThere are not as many treatment options for children with HIV as there are for adults living with HIV. But there are more options than ever, and maybe one more on the horizon. The FDA has accepted a New Drug Application to review a new dispersible tablet form of dolutegravir-lamivudine (Dovato, ViiV Healthcare) for children and lower the age range of the indication to include more children.Annie Buchanan, MD, MPH, DTMH, the pediatric medicines development lead for ViiV He
  
  Read more

• AI Model Predicts Underfeeding Risk in ICU Patients

  12-09-2026 04:38 via pharmacypracticenews.com
  
  Originally published by our sister publication Specialty Pharmacy Continuumfigure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }McMahon Group (AI)By Marcus A. BanksA machine learning model predicted whi
  
  Read more

Follow @newsl_pharmacy on Twitter!